Literature DB >> 30553368

Testosterone- and vitamin-grafted cellulose ethers for sustained release of camptothecin.

Javier Pérez Quiñones1, Cezarina Cela Mardare2, Achim Walter Hassel2, Oliver Brüggemann3.   

Abstract

Camptothecin (CPT), a potent anticancer drug with known antiviral activity, is halted of clinical use. Few drug delivery systems of CPT are approved for therapy. Hereby, we propose the encapsulation of hydrophobic CPT in the inner core of cellulose nanoaggregates for sustained release with retaining of antiproliferative activity. Cellulose conjugates were synthesized by esterification of methyl cellulose, hydroxyethyl cellulose and (hydroxypropyl)methyl cellulose with testosterone, ergocalciferol and dl-α-tocopherol hemisuccinates. The degree of substitution attained ranged from 0.004 to 0.025 and no depolymerization was observed by size exclusion chromatography. ATR-FTIR and NMR spectroscopies confirmed grafting of testosterone and vitamins to celluloses. According to dynamic light scattering, it resulted in their self-assembly in aqueous medium as stable and slightly negatively charged nanoaggregates of 213 to 731 nm. Nanoaggregates formation was also assessed using transmission electron and atomic force microscopies. CPT was encapsulated in the cellulose nanoaggregates, achieving a content of 1.7-13.0 wt %. Sustained release of camptothecin over 150 h was observed in simulated physiological conditions. CPT-loaded cellulose nanoparticles appeared to be possible candidates for chemotherapy, according to observed cytotoxicity against MCF-7 cancer cells.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Camptothecin; Cellulose; Self-assembled nanocarriers; Sustained release

Mesh:

Substances:

Year:  2018        PMID: 30553368     DOI: 10.1016/j.carbpol.2018.11.047

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  1 in total

1.  Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin.

Authors:  Javier Pérez Quiñones; Cornelia Roschger; Aitziber Iturmendi; Helena Henke; Andreas Zierer; Carlos Peniche-Covas; Oliver Brüggemann
Journal:  Pharmaceutics       Date:  2022-01-11       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.